O	0	10	Regulation	Regulation	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	26	transforming	transform	VBG	B-VP
O	27	33	growth	growth	NN	B-NP
O	34	40	factor	factor	NN	I-NP
O	40	41	-	-	HYPH	O
O	41	45	beta	beta	SYM	B-NP
O	46	55	signaling	signaling	NN	B-NP
O	56	59	and	and	CC	O
B-Multi-tissue_structure	60	68	vascular	vascular	JJ	B-NP
O	69	77	diseases	disease	NNS	I-NP
O	77	78	.	.	.	O

O	79	86	PURPOSE	PURPOSE	NN	B-NP
O	86	87	:	:	:	O
O	88	95	Members	Member	NNS	B-NP
O	96	98	of	of	IN	B-PP
O	99	102	the	the	DT	B-NP
O	103	115	transforming	transform	VBG	I-NP
O	116	122	growth	growth	NN	I-NP
O	123	129	factor	factor	NN	I-NP
O	130	131	(	(	(	O
O	131	134	TGF	TGF	NN	B-NP
O	134	135	)	)	)	O
O	135	136	-	-	HYPH	O
O	136	140	beta	beta	SYM	B-NP
O	141	152	superfamily	superfamily	NN	I-NP
O	153	157	play	play	VBP	B-VP
O	158	166	critical	critical	JJ	B-NP
O	167	172	roles	role	NNS	I-NP
O	173	175	in	in	IN	B-PP
O	176	186	regulation	regulation	NN	B-NP
O	187	189	of	of	IN	B-PP
O	190	197	various	various	JJ	B-NP
B-Cell	198	206	cellular	cellular	JJ	I-NP
O	207	216	functions	function	NNS	I-NP
O	216	217	.	.	.	O

O	218	231	Dysregulation	Dysregulation	NN	B-NP
O	232	234	of	of	IN	B-PP
O	235	238	the	the	DT	B-NP
O	239	248	signaling	signaling	NN	I-NP
O	249	259	mechanisms	mechanism	NNS	I-NP
O	260	262	of	of	IN	B-PP
O	263	266	the	the	DT	B-NP
O	267	270	TGF	TGF	NN	I-NP
O	270	271	-	-	HYPH	O
O	271	275	beta	beta	SYM	B-NP
O	276	287	superfamily	superfamily	NN	I-NP
O	288	296	proteins	protein	NNS	I-NP
O	297	299	is	be	VBZ	B-VP
O	300	310	associated	associate	VBN	I-VP
O	311	315	with	with	IN	B-PP
O	316	324	clinical	clinical	JJ	B-NP
O	325	333	diseases	disease	NNS	I-NP
O	334	338	such	such	JJ	B-PP
O	339	341	as	as	IN	I-PP
B-Cancer	342	348	cancer	cancer	NN	B-NP
O	348	349	,	,	,	O
O	350	358	fibrotic	fibrotic	JJ	B-NP
O	359	367	diseases	disease	NNS	I-NP
O	367	368	,	,	,	O
O	369	372	and	and	CC	O
B-Multi-tissue_structure	373	381	vascular	vascular	JJ	B-NP
O	382	391	disorders	disorder	NNS	I-NP
O	391	392	.	.	.	O

O	393	402	Therefore	Therefore	RB	B-ADVP
O	402	403	,	,	,	O
O	404	417	understanding	understand	VBG	B-VP
O	418	423	these	these	DT	B-NP
O	424	433	signaling	signaling	NN	I-NP
O	434	444	mechanisms	mechanism	NNS	I-NP
O	445	448	may	may	MD	B-VP
O	449	456	provide	provide	VB	I-VP
O	457	459	us	us	PRP	B-NP
O	460	464	with	with	IN	B-PP
O	465	470	novel	novel	JJ	B-NP
O	471	475	ways	way	NNS	I-NP
O	476	478	to	to	TO	B-VP
O	479	486	develop	develop	VB	I-VP
O	487	497	strategies	strategy	NNS	B-NP
O	498	501	for	for	IN	B-PP
O	502	510	treating	treat	VBG	B-VP
O	511	519	clinical	clinical	JJ	B-NP
O	520	528	diseases	disease	NNS	I-NP
O	529	536	induced	induce	VBN	B-VP
O	537	539	by	by	IN	B-PP
O	540	545	these	these	DT	B-NP
O	546	555	cytokines	cytokine	NNS	I-NP
O	555	556	.	.	.	O

O	557	564	METHODS	METHODS	NNS	B-NP
O	564	565	:	:	:	O
O	566	570	This	This	DT	B-NP
O	571	577	review	review	NN	I-NP
O	578	587	discusses	discuss	VBZ	B-VP
O	588	591	our	our	PRP$	B-NP
O	592	599	current	current	JJ	I-NP
O	600	613	understanding	understanding	NN	I-NP
O	614	616	of	of	IN	B-PP
O	617	620	the	the	DT	B-NP
O	621	631	mechanisms	mechanism	NNS	I-NP
O	632	634	of	of	IN	B-PP
O	635	638	TGF	TGF	NN	B-NP
O	638	639	-	-	HYPH	O
O	639	643	beta	beta	SYM	B-NP
O	644	653	signaling	signaling	NN	I-NP
O	653	654	,	,	,	O
O	655	663	focusing	focus	VBG	B-VP
O	664	666	on	on	IN	B-PP
O	667	670	the	the	DT	B-NP
O	671	676	roles	role	NNS	I-NP
O	677	679	of	of	IN	B-PP
O	680	683	TGF	TGF	NN	B-NP
O	683	684	-	-	HYPH	O
O	684	688	beta	beta	NN	B-NP
O	689	691	in	in	IN	B-PP
O	692	702	regulation	regulation	NN	B-NP
O	703	705	of	of	IN	B-PP
B-Cell	706	714	vascular	vascular	JJ	B-NP
I-Cell	715	719	wall	wall	NN	I-NP
I-Cell	720	725	cells	cell	NNS	I-NP
O	726	729	and	and	CC	B-PP
O	730	732	on	on	IN	B-PP
O	733	736	the	the	DT	B-NP
O	737	747	regulation	regulation	NN	I-NP
O	748	750	of	of	IN	B-PP
O	751	754	TGF	TGF	NN	B-NP
O	754	755	-	-	HYPH	O
O	755	759	beta	beta	SYM	B-NP
O	760	771	superfamily	superfamily	NN	I-NP
O	772	779	signals	signal	NNS	I-NP
O	780	782	by	by	IN	B-PP
O	783	793	inhibitory	inhibitory	JJ	B-NP
O	794	799	Smads	Smad	NNS	I-NP
O	799	800	.	.	.	O

